Transepidermal water loss rises before food anaphylaxis and predicts food challenge outcomes
Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis, causing discomfort and risk while limiting OFC utility. Transepidermal water loss (TEWL) measurement provides a potential solution to detect f...
Saved in:
Published in | The Journal of clinical investigation Vol. 133; no. 16; pp. 1 - 12 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Clinical Investigation
15.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis, causing discomfort and risk while limiting OFC utility. Transepidermal water loss (TEWL) measurement provides a potential solution to detect food anaphylaxis in real time prior to clinical symptoms. We evaluated whether TEWL changes during an OFC could predict anaphylaxis onset.
Physicians and nurses blind to TEWL results conducted and adjudicated the results of all 209 OFCs in this study. A study coordinator measured TEWL throughout the OFC and had no input on OFC conduct. TEWL was measured two ways in two separate groups. First, TEWL was measured using static, discrete measurements. Second, TEWL was measured using continuous monitoring. Participants who consented gave blood before and after OFCs for biomarker analyses.
TEWL rose significantly (2.93 g/m2/h) during reactions and did not rise during non-reacting OFCs (-1.00 g/m2/h). Systemic increases in tryptase and interleukin-3 were also detected during reactions, providing supporting biochemical evidence of anaphylaxis. The TEWL rise occurred 48 minutes earlier than clinically evident anaphylaxis. Continuous monitoring detected a significant rise in TEWL that presaged positive OFCs, but no rise was seen in OFCs with no reaction, providing high predictive specificity (96%) for anaphylaxis against non-reactions 38 minutes prior to anaphylaxis.
During OFCs, a TEWL rise anticipates a positive clinical challenge. TEWL presents a novel monitoring modality that may predict food anaphylaxis and facilitate improvements in OFC safety and tolerability. |
---|---|
AbstractList | BACKGROUND. Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis, causing discomfort and risk while limiting OFC utility. Transepidermal water loss (TEWL) measurement provides a potential solution to detect food anaphylaxis in real time prior to clinical symptoms. We evaluated whether TEWL changes during an OFC could predict anaphylaxis onset. METHODS. Physicians and nurses blinded to the TEWL results conducted and adjudicated the results of all 209 OFCs in this study. A study coordinator measured TEWL throughout the OFC and had no input on the OFC conduct. TEWL was measured 2 ways in 2 separate groups. First, TEWL was measured using static, discrete measurements. Second, TEWL was measured using continuous monitoring. Participants who consented provided blood samples before and afterthe OFCs for biomarker analyses. RESULTS. TEWL rose significantly (2.93 g/m2/h) during reactions and did not rise during nonreacting OFCs (-1.00 g/m2/h). Systemic increases in tryptase and IL-3 were also detected during reactions, providing supporting biochemical evidence of anaphylaxis. The TEWL rise occurred 48 minutes earlierthan clinically evident anaphylaxis. Continuous monitoring detected a significant rise in TEWL that presaged positive OFCs, but no rise was seen in the OFCs that resulted in no reaction, providing high predictive specificity (96%) for anaphylaxis against nonreactions 38 minutes priorto anaphylaxis onset. CONCLUSIONS. During OFCs, a TEWL rise anticipated a positive clinical challenge. TEWL presents a monitoring modality that may predict food anaphylaxis and facilitate improvements in OFC safety and tolerability. BACKGROUND. Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis, causing discomfort and risk while limiting OFC utility. Transepidermal water loss (TEWL) measurement provides a potential solution to detect food anaphylaxis in real time prior to clinical symptoms. We evaluated whether TEWL changes during an OFC could predict anaphylaxis onset. METHODS. Physicians and nurses blinded to the TEWL results conducted and adjudicated the results of all 209 OFCs in this study. A study coordinator measured TEWL throughout the OFC and had no input on the OFC conduct. TEWL was measured 2 ways in 2 separate groups. First, TEWL was measured using static, discrete measurements. Second, TEWL was measured using continuous monitoring. Participants who consented provided blood samples before and after the OFCs for biomarker analyses. RESULTS. TEWL rose significantly (2.93 g/m2/h) during reactions and did not rise during nonreacting OFCs (-1.00 g/[m.sup.2]/h). Systemic increases in tryptase and IL-3 were also detected during reactions, providing supporting biochemical evidence of anaphylaxis. The TEWL rise occurred 48 minutes earlier than clinically evident anaphylaxis. Continuous monitoring detected a significant rise in TEWL that presaged positive OFCs, but no rise was seen in the OFCs that resulted in no reaction, providing high predictive specificity (96%) for anaphylaxis against nonreactions 38 minutes prior to anaphylaxis onset. CONCLUSIONS. During OFCs, a TEWL rise anticipated a positive clinical challenge. TEWL presents a monitoring modality that may predict food anaphylaxis and facilitate improvements in OFC safety and tolerability. BACKGROUND Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis, causing discomfort and risk while limiting OFC utility. Transepidermal water loss (TEWL) measurement provides a potential solution to detect food anaphylaxis in real time prior to clinical symptoms. We evaluated whether TEWL changes during an OFC could predict anaphylaxis onset.METHODS Physicians and nurses blinded to the TEWL results conducted and adjudicated the results of all 209 OFCs in this study. A study coordinator measured TEWL throughout the OFC and had no input on the OFC conduct. TEWL was measured 2 ways in 2 separate groups. First, TEWL was measured using static, discrete measurements. Second, TEWL was measured using continuous monitoring. Participants who consented provided blood samples before and after the OFCs for biomarker analyses.RESULTS TEWL rose significantly (2.93 g/m2/h) during reactions and did not rise during nonreacting OFCs (–1.00 g/m2/h). Systemic increases in tryptase and IL-3 were also detected during reactions, providing supporting biochemical evidence of anaphylaxis. The TEWL rise occurred 48 minutes earlier than clinically evident anaphylaxis. Continuous monitoring detected a significant rise in TEWL that presaged positive OFCs, but no rise was seen in the OFCs that resulted in no reaction, providing high predictive specificity (96%) for anaphylaxis against nonreactions 38 minutes prior to anaphylaxis onset.CONCLUSIONS During OFCs, a TEWL rise anticipated a positive clinical challenge. TEWL presents a monitoring modality that may predict food anaphylaxis and facilitate improvements in OFC safety and tolerability. BACKGROUNDFood allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis, causing discomfort and risk while limiting OFC utility. Transepidermal water loss (TEWL) measurement provides a potential solution to detect food anaphylaxis in real time prior to clinical symptoms. We evaluated whether TEWL changes during an OFC could predict anaphylaxis onset.METHODSPhysicians and nurses blinded to the TEWL results conducted and adjudicated the results of all 209 OFCs in this study. A study coordinator measured TEWL throughout the OFC and had no input on the OFC conduct. TEWL was measured 2 ways in 2 separate groups. First, TEWL was measured using static, discrete measurements. Second, TEWL was measured using continuous monitoring. Participants who consented provided blood samples before and after the OFCs for biomarker analyses.RESULTSTEWL rose significantly (2.93 g/m2/h) during reactions and did not rise during nonreacting OFCs (-1.00 g/m2/h). Systemic increases in tryptase and IL-3 were also detected during reactions, providing supporting biochemical evidence of anaphylaxis. The TEWL rise occurred 48 minutes earlier than clinically evident anaphylaxis. Continuous monitoring detected a significant rise in TEWL that presaged positive OFCs, but no rise was seen in the OFCs that resulted in no reaction, providing high predictive specificity (96%) for anaphylaxis against nonreactions 38 minutes prior to anaphylaxis onset.CONCLUSIONSDuring OFCs, a TEWL rise anticipated a positive clinical challenge. TEWL presents a monitoring modality that may predict food anaphylaxis and facilitate improvements in OFC safety and tolerability.BACKGROUNDFood allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis, causing discomfort and risk while limiting OFC utility. Transepidermal water loss (TEWL) measurement provides a potential solution to detect food anaphylaxis in real time prior to clinical symptoms. We evaluated whether TEWL changes during an OFC could predict anaphylaxis onset.METHODSPhysicians and nurses blinded to the TEWL results conducted and adjudicated the results of all 209 OFCs in this study. A study coordinator measured TEWL throughout the OFC and had no input on the OFC conduct. TEWL was measured 2 ways in 2 separate groups. First, TEWL was measured using static, discrete measurements. Second, TEWL was measured using continuous monitoring. Participants who consented provided blood samples before and after the OFCs for biomarker analyses.RESULTSTEWL rose significantly (2.93 g/m2/h) during reactions and did not rise during nonreacting OFCs (-1.00 g/m2/h). Systemic increases in tryptase and IL-3 were also detected during reactions, providing supporting biochemical evidence of anaphylaxis. The TEWL rise occurred 48 minutes earlier than clinically evident anaphylaxis. Continuous monitoring detected a significant rise in TEWL that presaged positive OFCs, but no rise was seen in the OFCs that resulted in no reaction, providing high predictive specificity (96%) for anaphylaxis against nonreactions 38 minutes prior to anaphylaxis onset.CONCLUSIONSDuring OFCs, a TEWL rise anticipated a positive clinical challenge. TEWL presents a monitoring modality that may predict food anaphylaxis and facilitate improvements in OFC safety and tolerability. Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis, causing discomfort and risk while limiting OFC utility. Transepidermal water loss (TEWL) measurement provides a potential solution to detect food anaphylaxis in real time prior to clinical symptoms. We evaluated whether TEWL changes during an OFC could predict anaphylaxis onset. Physicians and nurses blind to TEWL results conducted and adjudicated the results of all 209 OFCs in this study. A study coordinator measured TEWL throughout the OFC and had no input on OFC conduct. TEWL was measured two ways in two separate groups. First, TEWL was measured using static, discrete measurements. Second, TEWL was measured using continuous monitoring. Participants who consented gave blood before and after OFCs for biomarker analyses. TEWL rose significantly (2.93 g/m2/h) during reactions and did not rise during non-reacting OFCs (-1.00 g/m2/h). Systemic increases in tryptase and interleukin-3 were also detected during reactions, providing supporting biochemical evidence of anaphylaxis. The TEWL rise occurred 48 minutes earlier than clinically evident anaphylaxis. Continuous monitoring detected a significant rise in TEWL that presaged positive OFCs, but no rise was seen in OFCs with no reaction, providing high predictive specificity (96%) for anaphylaxis against non-reactions 38 minutes prior to anaphylaxis. During OFCs, a TEWL rise anticipates a positive clinical challenge. TEWL presents a novel monitoring modality that may predict food anaphylaxis and facilitate improvements in OFC safety and tolerability. |
Audience | Academic |
Author | Cannon, Jayme Lukacs, Nicholas W. Kaul, Bridgette Hogan, Simon P. Troost, Jonathan P. Baker, James R. O’Shea, Kelly M. Sanders, Georgiana M. Launius, Christopher M. Freigeh, George E. Manthei, David M. Schuler, Charles F. |
AuthorAffiliation | 1 Division of Allergy and Clinical Immunology, Department of Internal Medicine 2 Mary H. Weiser Food Allergy Center 4 Michigan Nanotechnology Institute for the Biomedical Sciences, and 3 Michigan Institute for Clinical Health Research 5 Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA |
AuthorAffiliation_xml | – name: 4 Michigan Nanotechnology Institute for the Biomedical Sciences, and – name: 3 Michigan Institute for Clinical Health Research – name: 1 Division of Allergy and Clinical Immunology, Department of Internal Medicine – name: 2 Mary H. Weiser Food Allergy Center – name: 5 Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA |
Author_xml | – sequence: 1 givenname: Charles F. surname: Schuler fullname: Schuler, Charles F. – sequence: 2 givenname: Kelly M. orcidid: 0000-0002-8147-4480 surname: O’Shea fullname: O’Shea, Kelly M. – sequence: 3 givenname: Jonathan P. surname: Troost fullname: Troost, Jonathan P. – sequence: 4 givenname: Bridgette surname: Kaul fullname: Kaul, Bridgette – sequence: 5 givenname: Christopher M. surname: Launius fullname: Launius, Christopher M. – sequence: 6 givenname: Jayme surname: Cannon fullname: Cannon, Jayme – sequence: 7 givenname: David M. surname: Manthei fullname: Manthei, David M. – sequence: 8 givenname: George E. surname: Freigeh fullname: Freigeh, George E. – sequence: 9 givenname: Georgiana M. surname: Sanders fullname: Sanders, Georgiana M. – sequence: 10 givenname: Simon P. orcidid: 0000-0001-5793-4304 surname: Hogan fullname: Hogan, Simon P. – sequence: 11 givenname: Nicholas W. surname: Lukacs fullname: Lukacs, Nicholas W. – sequence: 12 givenname: James R. surname: Baker fullname: Baker, James R. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37402149$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk01v1DAQhiNURNuFA38ARUJCcNg2_oiTnFC14mNRpUpQOCFZjj3JunLsxXag_fd42bJsqj0gHzwaP_OO7Zk5zY6ss5Blz1FxhlCFzz8tlojVDSsfZSeoLOt5jUl9tGcfZ6ch3BQForSkT7JjUtECI9qcZN-vvbAB1lqBH4TJf4kIPjcuhNzrACFvoXMe8s45lQsr1qs7I251SLbK1x6UljFsT-VKGAO2h9yNUboBwtPscSdMgGf3-yz7-v7d9eLj_PLqw3JxcTmXrKJxjgokkJCtKjsFiAjKWFUmu6lqQrHETYcpw01Rt1R2pCW4UVg1DEBRKFHdkVm23OoqJ2742utB-DvuhOZ_HM73XPiopQFOCopLAY0UglGm2loVVNZKYkiJUBKfZW-3WuuxHUBJsNELMxGdnli94r37ydFGGSOcFF7fK3j3Y4QQ-aCDBGOEBTcGjmtCGK1QyRL68gF640Zv018liiFCWblP9SK9QNvOpcRyI8ovKobqgjRNkaj5AaoHC-mWqV86ndwT_uwAn5aCQcuDAW8mAYmJcBt7MYbAl18-_z979W3KvtpjVyBMXAVnxqidDVPwxX5pdjX5283_skqfGthDt0NQwTeTwneTktjzB6zUUWxypm_Q5kDEb5zhEKw |
CitedBy_id | crossref_primary_10_1016_j_jacig_2024_100252 crossref_primary_10_1021_acssensors_3c01936 crossref_primary_10_1111_all_16017 |
Cites_doi | 10.1001/jamanetworkopen.2018.5630 10.1007/s00431-018-3274-z 10.1016/j.iac.2019.07.003 10.1016/j.jaci.2014.06.032 10.1111/j.1398-9995.2012.02788.x 10.1111/srt.12711 10.1080/08941939.2021.1922553 10.1136/bmjopen-2019-033801 10.1016/j.jaci.2010.05.018 10.1111/all.15443 10.1111/all.13143 10.1016/j.jaci.2013.05.038 10.1111/pai.12016 10.1111/j.1365-2222.2011.03905.x 10.1016/j.jaip.2019.09.029 10.1542/peds.2018-1235 10.1016/j.jaci.2014.05.013 10.1111/j.1398-9995.2007.01363.x 10.1016/j.jid.2018.09.001 10.1016/j.jaip.2020.09.037 10.4049/jimmunol.74.5.387 10.1016/j.jaip.2021.01.010 10.1126/scitranslmed.aav2685 10.1067/mai.2002.125977 10.1016/j.jaci.2010.11.044 10.1016/j.immuni.2015.08.020 10.1111/j.1365-2249.2008.03714.x 10.1084/jem.20071046 10.1016/j.jbi.2019.103208 10.1056/NEJMoa1200435 10.1016/j.jaip.2018.11.010 10.1371/journal.pone.0150819 10.1016/j.anai.2019.01.014 10.1016/j.jaci.2020.10.044 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 American Society for Clinical Investigation Copyright American Society for Clinical Investigation Aug 2023 2023 Schuler et al. 2023 Schuler et al. |
Copyright_xml | – notice: COPYRIGHT 2023 American Society for Clinical Investigation – notice: Copyright American Society for Clinical Investigation Aug 2023 – notice: 2023 Schuler et al. 2023 Schuler et al. |
DBID | AAYXX CITATION NPM IOV ISR 3V. 7RV 7X7 7XB 88A 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI S0X 7X8 5PM DOA |
DOI | 10.1172/JCI168965 |
DatabaseName | CrossRef PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials SIRS Editorial elibrary ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-8238 |
EndPage | 12 |
ExternalDocumentID | oai_doaj_org_article_30425ae9caa646db8d04c8dc2e2c213b PMC10425212 A761803990 37402149 10_1172_JCI168965 |
Genre | Journal Article |
GeographicLocations | United States United States--US |
GeographicLocations_xml | – name: United States – name: United States--US |
GrantInformation_xml | – fundername: ; grantid: NA – fundername: ; grantid: 9026 – fundername: University of Michigan Mary H. Weiser Food Allergy Center grantid: MFARA Pilot Grant – fundername: University of Michigan grantid: NA – fundername: NIAID grantid: K23AI162661 – fundername: ; grantid: UM1TR004404 |
GroupedDBID | --- -~X .55 .XZ 08G 08P 29K 354 36B 5GY 5RE 5RS 7RV 7X7 88E 8AO 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAWTL AAYXX ABOCM ABPMR ABUWG ACGFO ACIHN ACNCT ACPRK ADBBV AEAQA AENEX AFCHL AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS ASPBG AVWKF AZFZN BAWUL BBNVY BCU BEC BENPR BHPHI BKEYQ BLC BPHCQ BVXVI CCPQU CITATION CS3 D-I DIK DU5 E3Z EBS EJD EMB EX3 F5P FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR IHW INH IOF IOV IPO ISR ITC KQ8 L7B LK8 M1P M5~ M7P NAPCQ OBH OCB ODZKP OFXIZ OGEVE OHH OK1 OVD OVIDX OVT P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RPM S0X SJFOW SV3 TEORI TR2 TVE UKHRP VVN W2D WH7 WOQ WOW X7M XSB YFH YHG YKV YOC ZY1 ~H1 NPM PJZUB PPXIY PQGLB PMFND 3V. 7XB 88A 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c674t-101a1acbd5fde13a466755fd978342c29f2462908b4cf3b329d2d96eed4e518f3 |
IEDL.DBID | 7X7 |
ISSN | 1558-8238 0021-9738 |
IngestDate | Wed Aug 27 01:24:08 EDT 2025 Thu Aug 21 18:40:43 EDT 2025 Fri Jul 11 11:40:38 EDT 2025 Fri Jul 25 19:32:55 EDT 2025 Tue Jun 17 21:26:22 EDT 2025 Fri Jun 13 00:13:51 EDT 2025 Tue Jun 10 21:22:50 EDT 2025 Fri Jun 27 05:47:28 EDT 2025 Fri Jun 27 05:35:53 EDT 2025 Thu May 22 21:12:32 EDT 2025 Mon Jul 21 06:05:02 EDT 2025 Tue Jul 01 01:53:46 EDT 2025 Thu Apr 24 23:03:23 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 16 |
Keywords | Allergy Inflammation Immunology Diagnostics Clinical practice |
Language | English |
License | http://creativecommons.org/licenses/by/4.0 This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c674t-101a1acbd5fde13a466755fd978342c29f2462908b4cf3b329d2d96eed4e518f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Authorship note: NWL and JRB contributed equally to this work. |
ORCID | 0000-0002-8147-4480 0000-0001-5793-4304 |
OpenAccessLink | https://doaj.org/article/30425ae9caa646db8d04c8dc2e2c213b |
PMID | 37402149 |
PQID | 2861346556 |
PQPubID | 42166 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_30425ae9caa646db8d04c8dc2e2c213b pubmedcentral_primary_oai_pubmedcentral_nih_gov_10425212 proquest_miscellaneous_2833647156 proquest_journals_2861346556 gale_infotracmisc_A761803990 gale_infotracgeneralonefile_A761803990 gale_infotracacademiconefile_A761803990 gale_incontextgauss_ISR_A761803990 gale_incontextgauss_IOV_A761803990 gale_healthsolutions_A761803990 pubmed_primary_37402149 crossref_primary_10_1172_JCI168965 crossref_citationtrail_10_1172_JCI168965 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-08-15 |
PublicationDateYYYYMMDD | 2023-08-15 |
PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-15 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Ann Arbor |
PublicationTitle | The Journal of clinical investigation |
PublicationTitleAlternate | J Clin Invest |
PublicationYear | 2023 |
Publisher | American Society for Clinical Investigation |
Publisher_xml | – name: American Society for Clinical Investigation |
References | B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 B30 B31 B10 B32 B11 B33 B12 B34 B13 B14 B15 B16 B17 B18 B19 B1 B2 B3 B4 B5 B6 B7 B8 B9 |
References_xml | – ident: B2 doi: 10.1001/jamanetworkopen.2018.5630 – ident: B9 doi: 10.1007/s00431-018-3274-z – ident: B33 doi: 10.1016/j.iac.2019.07.003 – ident: B29 doi: 10.1016/j.jaci.2014.06.032 – ident: B13 doi: 10.1111/j.1398-9995.2012.02788.x – ident: B15 doi: 10.1111/srt.12711 – ident: B20 doi: 10.1080/08941939.2021.1922553 – ident: B26 doi: 10.1136/bmjopen-2019-033801 – ident: B4 doi: 10.1016/j.jaci.2010.05.018 – ident: B24 doi: 10.1111/all.15443 – ident: B18 doi: 10.1111/all.13143 – ident: B8 doi: 10.1016/j.jaci.2013.05.038 – ident: B10 doi: 10.1111/pai.12016 – ident: B12 doi: 10.1111/j.1365-2222.2011.03905.x – ident: B31 doi: 10.1016/j.jaip.2019.09.029 – ident: B1 doi: 10.1542/peds.2018-1235 – ident: B11 doi: 10.1016/j.jaci.2014.05.013 – ident: B14 doi: 10.1111/j.1398-9995.2007.01363.x – ident: B16 doi: 10.1016/j.jid.2018.09.001 – ident: B30 doi: 10.1016/j.jaip.2020.09.037 – ident: B23 doi: 10.4049/jimmunol.74.5.387 – ident: B5 doi: 10.1016/j.jaip.2021.01.010 – ident: B17 doi: 10.1126/scitranslmed.aav2685 – ident: B21 doi: 10.1067/mai.2002.125977 – ident: B6 doi: 10.1016/j.jaci.2010.11.044 – ident: B28 doi: 10.1016/j.immuni.2015.08.020 – ident: B19 doi: 10.1111/j.1365-2249.2008.03714.x – ident: B27 doi: 10.1084/jem.20071046 – ident: B32 doi: 10.1016/j.jbi.2019.103208 – ident: B34 doi: 10.1056/NEJMoa1200435 – ident: B7 doi: 10.1016/j.jaip.2018.11.010 – ident: B22 doi: 10.1371/journal.pone.0150819 – ident: B3 doi: 10.1016/j.anai.2019.01.014 – ident: B25 doi: 10.1016/j.jaci.2020.10.044 |
SSID | ssj0014454 |
Score | 2.4611337 |
Snippet | Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical anaphylaxis,... BACKGROUND. Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical... BACKGROUNDFood allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical... BACKGROUND Food allergy (FA) is a growing health problem requiring physiologic confirmation via the oral food challenge (OFC). Many OFCs result in clinical... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1 |
SubjectTerms | Analysis Anaphylaxis Biomedical research Clinical Medicine Dermatitis Development and progression Diagnosis Food allergies Food allergy Health aspects Immunology Inflammation Interleukin 3 Methods Permeability Prognosis Risk factors Skin Skin tests Tryptase Water in the body Water loss |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2ggEEIuERdO7ZjH0tF1VYqSEBRD0iRXymVVkm1yQp-PjOJN9qISnDgFsVfEmdmPDNO7G8IeV1KKR3krbnngeciRp07U6jcsRLCaTTOONzvfPpRHZ2Jk3N5vlXqC9eEjfTAo-D2cLotbTTeWiVUcDoshNfB88g9Z4VD7wsxbzOZSv8PhJAi8QhBhN47OThmShuMIFvRZyDp_9MVb8Wi-TrJrcBzeIfcThkj3R97epfciM09cvM0_RO_T74P4SZipVdwskv6E7LHFV3C4ykM4NhRFyExjbRu20Btg_zUS_vrsoPjQK9WeJ--G1v9prIKbdc9mGLsHpCzww9fD47yVDMh96oUPXhVZpn1Lsg6RFZYoWBGAMf4hUeAxEzNheJmoZ3wdeEKbgIPRkGkFFEyXRcPyU7TNvExoQVTsrRRhYX0otZBR1ZLa-BWNS9d1Bl5t5Fl5ROhONa1WFbDxKLk1ST2jLyaoFcji8Z1oPeokAmAxNfDCTCHKplD9TdzyMgLVGc17iKdhm-1XyqmF5CNLaAvAwLJLxpcXXNh111XHX_69g-gL59noLcJVLfw4t6mHQ0gPiTVmiHfzJAXI6X4dcDdGRDGup83b6y0Sr6mq7iGlAxp8FRGXk7NeCWun2tiu0ZMgYUCGGIejUY9ybkoBRLnmYzombnPFDFvaS5_DEzkDLUByc-T_6G6p-QWhwwSP9gzuUt2-tU6PoOMr3fPh8H9G7zkVMk priority: 102 providerName: Directory of Open Access Journals |
Title | Transepidermal water loss rises before food anaphylaxis and predicts food challenge outcomes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37402149 https://www.proquest.com/docview/2861346556 https://www.proquest.com/docview/2833647156 https://pubmed.ncbi.nlm.nih.gov/PMC10425212 https://doaj.org/article/30425ae9caa646db8d04c8dc2e2c213b |
Volume | 133 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgkxAviDuFUQJCwEu02rEd-wltY9M6tIEGQ32YFMWXlElVUppW8PM5J3FDIybEWxp_SRPb5-KT4-8Q8joVQhjwW2PLHIu59yo2OpGxoSmYU6-NNrjf-fRMHl_wk4mYhIBbHdIq1zqxUdSushgj32UKDA-Sfcn38x8xVo3Cr6uhhMZNso3UZZjSlU66BResFURgYaaxThMVmIXAZu-eHIypVBptyoY9amj7_1bOG9apnzm5YYqO7pI7wYeM9tpBv0du-PI-uXUavpI_IJeNAfJY-xXU7iz6Cf7kIprB30cg0r6OjAdX1UdFVbkoL5Gxepb_uqrh2EXzBd5nWbetdl1rJapWS-goXz8kF0eHXw-O41BFIbYy5UvQszSnuTVOFM7TJOcS1ghwjDEfzizTBeOS6ZEy3BaJSZh2zGkJtpN7QVWRPCJbZVX6JyRKqBRp7qUbCcsL5ZSnhcg13KpgqfFqQN6t-zKzgWIcK13MsmapkbKs6_YBedVB5y2vxnWgfRyQDoBU2M2JajHNgmRlGI8Rudc2zyWXzig34lY5yzy8HE3MgLzA4czafaWdQGd7qaRqBP7ZCJ6lQSAdRon5NtN8VdfZ-NO3_wB9Oe-B3gZQUcGL2zzscYDuQ5qtHvJNDzltScavA-70gCD9tt-8nqVZ0D519kdWBuRl14xXYkZd6asVYhIsHUAR87id1F0_JylHKj09IKo33XsD0W8pr7433OQURwPcoaf_fq5n5DYDbxGD81TskK3lYuWfg3e3NMNGhIdke__w7PM5_Pow_jhsIiW_Af4QUQY |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVAIuiDeBQg3i0YvV7Hq9Xh8Qakurpm0CKi3qAcnsy6FSZIc4UeFP8RuZsR0Tiwpx6c3yfl7bM7szs69vCHkZhWGoIW71DbPM585JX8eB8DWNwJ26WMcazzsPhmL_lB-chWcr5NfiLAxuq1zYxNJQ29zgHPkmk-B4kOxLvJt89zFrFK6uLlJoVM3i0P28gCFb8bb_HvT7irG93ZOdfb_OKuAbEfEZ2B2qqDLahql1NFBcQMwM1zgHwplhccq4YHFPam7SQAcstszGAnwJdyGVaQD1XiOrPIChTIesbu8OPx436xachzXvM_XjKJA1lxFECZsHO30qZIxebMkDlokC_nYHS_6wvVdzyfnt3Sa36qjV26qa2R2y4rK75PqgXpe_R76ULs9htlkw9GPvAiLYqTeG13tgRFzhaQfBsfPSPLeeypAje6x-nBdwbb3JFOuZFVWpWWR38fL5DFTjivvk9Eok_IB0sjxzj4gXUBFGygnbCw1PpZWOpqGKoaqURdrJLtlYyDIxNak55tYYJ-XgJmJJI_YuedFAJxWTx2WgbVRIA0Dy7fJGPh0ldV9OcAYoVC42SgkurJa2x420hjn4ORroLllHdSbVSdbGhCRbkaCyBxFhD76lRCABR4Y7fEZqXhRJ_8Pn_wB9Om6B3tSgNIcfN6o-VQHiQ2KvFvJ1CzmqaM0vA661gGBvTLt40UqT2t4VyZ_e2SXPm2J8EvfwZS6fIybAZAUUMQ-rRt3IOYg4kvfFXSJbzb2liHZJdv6tZEOnqA0IwB7_-7vWyY39k8FRctQfHj4hNxnEqrg0QMM10plN5-4pxJYz_azu0B75etU25Dfdfoub |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiDcLhQbE6xLt2okd-4BQaam6LS0IKNoDUvArS6VVsmx2Vfhr_DpmkmzYiApx6S2KvziJZzwzfn1DyJOEc24gbg0tcyyMvZehUZEIDU3AnXpllMHzzkfHYv8kPhjx0Rr5tTwLg9sqlzaxMtSusDhH3mcSHA-SfYl-1myLeL-792r6PcQMUrjSukynUavIof95BsO38uVwF2T9lLG9N5929sMmw0BoRRLPwQZRTbU1jmfO00jHAuJnuMb5kJhZpjIWC6YG0sQ2i0zElGNOCfArsedUZhHUe4lcTiJOsY8lo3awB-MU3jBA01AlkWxYjSBe6B_sDKmQCv3Zii-sUgb87RhWPGN31-aKG9y7Rq428WuwXSvcdbLm8xtk46hZob9JvlTOz2PeWTD5k-AMYtlZMIHXB2BOfBkYD2GyD7KicIHOkS17on-clnDtgukM65mXdald5nkJisUchOTLW-TkQtr3NlnPi9zfJUFEBU-0F27AbZxJJz3NuFZQVcYS42WPvFi2ZWobenPMsjFJq2FOwtK22XvkcQud1pwe54Feo0BaANJwVzeK2ThtenWKc0Fce2W1FrFwRrpBbKWzzMPP0cj0yBaKM63PtLbGJN1OBJUDiA0H8C0VAqk4clTqsV6UZTp89_k_QB8_dEDPG1BWwI9b3ZyvgOZDiq8O8lkHOa4Jzs8DbnaAYHlst3ippWlj-cr0Tz_tkUdtMT6Ju_lyXywQE2HaAoqYO7VSt-0cJTHS-KkekR117wiiW5Kffqt40SlKA0Kxe__-ri2yAZYjfTs8PrxPrjAIWnGNgPJNsj6fLfwDCDLn5mHVmwPy9aLNx2_LjI5r |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transepidermal+water+loss+rises+before+food+anaphylaxis+and+predicts+food+challenge+outcomes&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Iv%2C+Charles+F.+Schuler&rft.au=OShea%2C+Kelly+M&rft.au=Troost%2C+Jonathan+P&rft.au=Kaul%2C+Bridgette&rft.date=2023-08-15&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.volume=133&rft.issue=16&rft_id=info:doi/10.1172%2FJCI168965&rft.externalDocID=A761803990 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-8238&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-8238&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-8238&client=summon |